If just a single clinical trial works in favor of Cara Therapeutics, it could regain everything it’s recently lost and possibly hit a $1 billion market cap.
Tag Archives: Osteoarthritis
On May 2, 2016, the Illinois Medical Cannabis Advisory Board met to review a request to expand the state’s number of qualifying conditions. According to the Associated Press, the board voted to recommend diabetes and panic disorder as qualifying conditions.
On Monday, May 2, 2016, the Illinois Medical Cannabis Advisory Board will meet to discuss the possibility of approving additional conditions for the state’s list of conditions that can qualify a patient to use medical cannabis.
Zynerba presented the status of its research program at BIO Investor Forum. This is a 14-year-old annual biotech gathering, with roughly 600 attendees from 21 countries, and the presentation, in San Francisco, looked likely to be a big event in this company’s development.
The first Health Canada-approved clinical trial for medical cannabis has started patient recruitment to determine the pain-relieving characteristics of vaporized cannabis.